Member Info for ihavenoclue

BB, he does and he puts the legwork in. What has been mentioned on here is just a fraction of the info he has found for the GDR twitter group.

Andy, completely missed out Beckman validation news due next week which is more important than all you have mentioned.

Glue, with some of the figures Beckman talking about their new automated process within a month even a fraction of that makes me a ramper then I guess.

Glue, what figure SP would you say constitutes ramping?

"JB is running on fumes literally on his last few shares." He has the rest of this week to offload so I am not sure why you are coming up with this BS when it is all RNS'ed ???

"So many people dont know what 'dead cat bounce' means."

It's very clear that Hardcore1 doesn't !!

How is ODX news affecting us? This pattern has been going on for weeks here

Who is puzzled? Sub £1 is far too cheap!!!

grim ... and one tech can man two of those machines as per RNS ?

Worth remembering that part of the process had already been completed on the 4th August

"Genedrive has already completed initial evaluation of Beckman Coulter's RNA extraction chemistry to confirm compatibility with the Genedrive 96 SARS-CoV-2 test."

Then there is the timetable from the 4th August

"We are both working to have the ongoing validation completed in approximately 6 weeks, with initial introduction in the USA at an already identified clinical laboratory.""

Then the sting in the tail

"The integrated Genedrive/Beckman Coulter solution will be introduced in selected, relevant geographies subject to validation and any required regulatory approvals."

Would be great to get EUA before validation ends but if Beckman like what they see at the end of the process I can see it being a formality as they will help it along.

All IMHO

Jh, he goes into a lot of detail with figures too but if I mentioned even half of what is capable then I will be accused of mass ramping.

Perfectly possible ST the Americans do love their NDAs

Well yes, if the numbers aren't there then your outcome is correct.

Disagree and I don't think you realise the scale the collaboration will bring to GDR.

Who is the better salesman. The one who gets 100 orders for £1k each or the one who gets 1 for £1m?

Time will tell if the collaboration is as good as I believe it will be.

Yes a collaboration with Beckman shows really foolish management I must say.

This is AIM and there has been no news so it will drift but it has been in 88 - 98 range for weeks so I fail to see any surprise or panic?

I am in for Beckman news and that is still on so I still hold and I have added as at the lower end of the range.

They CAN'T sell a single test till they get approvals. What a stupid comment to make.

I see the derampers are out in force as chat awash in green.

I bought more as fundamentals haven't changed. If you don't think GDR will sell tests then sell up and I will be buying.

... and then hang around and bash it?

GDR can do about as much to speed the approval process up as you can stop it raining so the daily whinging about the delay is POINTLESS.

If you do not believe GDR will sell any tests then sell up and move on.

If you have bought, or even added on Beckman news, then the fundamentals have NOT changed.

Patience is a skill some of you clearly need to master.

PP, cheers. Yes not much to add at the moment. If approval isn't before the validation and Beckman like what they see I am confident it won't be long after.

Whereas I may not agree with how Lp puts things at time I do agree that Genedrive will succeed due to Beckman. Without that tie in I would certainly still not be here and I would have moved my money elsewhere but I have not sold a single share since the RNS on the 4th August and I have been adding.

The 'shorters' were correct that genedrive had a gold standard product but no sales and without approvals were just treading water. The Beckman news came out of the blue and filled in several large gaps that Genedrive really needed to stand any chance of doing well (in fact the only box they really had ticked was Gold Standard Test)

Market - As a UK Company into the US market we were the poor boy looking into the window of the rich mans house hoping for scraps but the Beckman tie in, if they are happy with what they see during validation - and even the shorters agree it is a gold standard test ;) , will actually allow Genedrive a seat at the table in what is a market that is screaming out for quick reliable tests (News reference Bill Gates who's foundation owns 13.66% of GDR - hmmmm)

Infrastructure - Genedrive could have scaled up to meet some demand but what Beckman offer them, and the locations - right where demand is greatest state by state, they wouldn't have been able to do that without the collaboration.

Demand - Other than India the US is one of the worst effected countries so to be able to base production in the demand's 'back yard' as it were is spot on. Price per test will certainly not be an issue in the US either.

Approval - As it has been mentioned US companies are in the front of the queue for approval and UK companies have to wait their turn. If we don't get approval before validation, and Beckman really like what they see, I can see that approval won't take long after that with their leverage in the US.

In fact I believe Beckman bring a lot more to the collaboration than Genedrive (Genedrive being a piece of the pie) and I believe that Beckman (once again if happy with the validation phase) might just put in an offer to buy Genedrive to have it all for themselves and get Genedrives other products as a bonus. May not even get the chance to get any sales in India and the 10 other countries mentioned.

And I do not believe £200m - 250m is out of the question either so when I see £3.84 rubbished as ramping fantasy I wonder if people truly grasp what could happen in what may be a very short space of time ?

Have I been naughty?

You do remind me of a teenager who has had their playstation taken away and everything they say from that moment forward is negative. You don't always have to be positive but some balance wouldn't go amiss and to listen to a different point of view isn't going to kill you.